RU2010142003A - Синбиотическая смесь - Google Patents
Синбиотическая смесь Download PDFInfo
- Publication number
- RU2010142003A RU2010142003A RU2010142003/10A RU2010142003A RU2010142003A RU 2010142003 A RU2010142003 A RU 2010142003A RU 2010142003/10 A RU2010142003/10 A RU 2010142003/10A RU 2010142003 A RU2010142003 A RU 2010142003A RU 2010142003 A RU2010142003 A RU 2010142003A
- Authority
- RU
- Russia
- Prior art keywords
- drug
- nutritional composition
- lactobacillus
- lactosamine
- acetyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract 13
- 235000019722 synbiotics Nutrition 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract 14
- 229940079593 drug Drugs 0.000 claims abstract 14
- 235000016709 nutrition Nutrition 0.000 claims abstract 10
- KFEUJDWYNGMDBV-UHFFFAOYSA-N (N-Acetyl)-glucosamin-4-beta-galaktosid Natural products OC1C(NC(=O)C)C(O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 KFEUJDWYNGMDBV-UHFFFAOYSA-N 0.000 claims abstract 6
- KFEUJDWYNGMDBV-LODBTCKLSA-N N-acetyllactosamine Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KFEUJDWYNGMDBV-LODBTCKLSA-N 0.000 claims abstract 6
- HESSGHHCXGBPAJ-UHFFFAOYSA-N N-acetyllactosamine Natural products CC(=O)NC(C=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O HESSGHHCXGBPAJ-UHFFFAOYSA-N 0.000 claims abstract 6
- 208000015181 infectious disease Diseases 0.000 claims abstract 6
- 241000186604 Lactobacillus reuteri Species 0.000 claims abstract 4
- 229940001882 lactobacillus reuteri Drugs 0.000 claims abstract 4
- 238000004519 manufacturing process Methods 0.000 claims abstract 4
- 229920001542 oligosaccharide Polymers 0.000 claims abstract 4
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract 4
- 230000001717 pathogenic effect Effects 0.000 claims abstract 4
- 230000002265 prevention Effects 0.000 claims abstract 4
- 239000006041 probiotic Substances 0.000 claims abstract 4
- 230000000529 probiotic effect Effects 0.000 claims abstract 4
- 235000018291 probiotics Nutrition 0.000 claims abstract 4
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract 2
- 241000917009 Lactobacillus rhamnosus GG Species 0.000 claims abstract 2
- 241000186610 Lactobacillus sp. Species 0.000 claims abstract 2
- -1 N-acetyl-lactosamine Chemical class 0.000 claims abstract 2
- AXQLFFDZXPOFPO-UHFFFAOYSA-N UNPD216 Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC(C1O)C(O)C(CO)OC1OC1C(O)C(O)C(O)OC1CO AXQLFFDZXPOFPO-UHFFFAOYSA-N 0.000 claims abstract 2
- 244000052616 bacterial pathogen Species 0.000 claims abstract 2
- AXQLFFDZXPOFPO-UNTPKZLMSA-N beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO AXQLFFDZXPOFPO-UNTPKZLMSA-N 0.000 claims abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract 2
- IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 claims abstract 2
- USIPEGYTBGEPJN-UHFFFAOYSA-N lacto-N-tetraose Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC1C(O)C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C1O USIPEGYTBGEPJN-UHFFFAOYSA-N 0.000 claims abstract 2
- 229940062780 lacto-n-neotetraose Drugs 0.000 claims abstract 2
- 229940035901 lactobacillus sp Drugs 0.000 claims abstract 2
- RBMYDHMFFAVMMM-PLQWBNBWSA-N neolactotetraose Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RBMYDHMFFAVMMM-PLQWBNBWSA-N 0.000 claims abstract 2
- 210000002345 respiratory system Anatomy 0.000 claims abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pediatric Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
1. Препарат, содержащий N-ацетил-лактозамин и/или олигосахарид, включающий N-ацетил-лактозамин, и пробиотический Lactobacillus sp. ! 2. Препарат по п.1, в котором олигосахарид, содержащий N-ацетил-лактозамин, представляет собой лакто-N-тетраозу или лакто-N неотетраозу. ! 3. Препарат по п.1 или 2, в котором пробиотический Lactobacillus sp представляет собой Lactobacillus rhamnosus ATCC 53103, Lactobacillus rhamnosus CGMCC 1.3724, Lactobacillus reuteri ATCC 55730 или Lactobacillus reuteri DSM 17938. ! 4. Питательная композиция, содержащая препарат по любому предшествующему пункту. ! 5. Питательная композиция по п.4, которая представляет собой смесь для младенцев. ! 6. Питательная композиция по п.4 или 5, которая содержит от 0,3 до 4 мас.% препарата по любому из пп.1-3 в расчете на сухую массу. ! 7. Применение препарата по любому из пп.1-3 в производстве питательной композиции или лекарственного средства для предотвращения или лечения патогенных инфекций желудочно-кишечного тракта. ! 8. Применение препарата по любому из пп.1-3 в производстве питательной композиции или лекарственного средства для предотвращения или лечения патогенных инфекций верхних дыхательных путей. ! 9. Применение по п.7 или 8, когда инфекцию вызывают болезнетворные бактерии.
Claims (9)
1. Препарат, содержащий N-ацетил-лактозамин и/или олигосахарид, включающий N-ацетил-лактозамин, и пробиотический Lactobacillus sp.
2. Препарат по п.1, в котором олигосахарид, содержащий N-ацетил-лактозамин, представляет собой лакто-N-тетраозу или лакто-N неотетраозу.
3. Препарат по п.1 или 2, в котором пробиотический Lactobacillus sp представляет собой Lactobacillus rhamnosus ATCC 53103, Lactobacillus rhamnosus CGMCC 1.3724, Lactobacillus reuteri ATCC 55730 или Lactobacillus reuteri DSM 17938.
4. Питательная композиция, содержащая препарат по любому предшествующему пункту.
5. Питательная композиция по п.4, которая представляет собой смесь для младенцев.
6. Питательная композиция по п.4 или 5, которая содержит от 0,3 до 4 мас.% препарата по любому из пп.1-3 в расчете на сухую массу.
7. Применение препарата по любому из пп.1-3 в производстве питательной композиции или лекарственного средства для предотвращения или лечения патогенных инфекций желудочно-кишечного тракта.
8. Применение препарата по любому из пп.1-3 в производстве питательной композиции или лекарственного средства для предотвращения или лечения патогенных инфекций верхних дыхательных путей.
9. Применение по п.7 или 8, когда инфекцию вызывают болезнетворные бактерии.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08152765.7 | 2008-03-14 | ||
| EP08152765 | 2008-03-14 | ||
| PCT/EP2009/052166 WO2009112361A2 (en) | 2008-03-14 | 2009-02-24 | Synbiotic mixture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2010142003A true RU2010142003A (ru) | 2012-04-20 |
| RU2495927C2 RU2495927C2 (ru) | 2013-10-20 |
Family
ID=39780479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010142003/10A RU2495927C2 (ru) | 2008-03-14 | 2009-02-24 | Синбиотическая смесь |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US8961953B2 (ru) |
| EP (1) | EP2265135B1 (ru) |
| CN (1) | CN102006788A (ru) |
| AU (1) | AU2009224814B2 (ru) |
| BR (1) | BRPI0909289A2 (ru) |
| CA (1) | CA2718222A1 (ru) |
| ES (1) | ES2658837T3 (ru) |
| MX (1) | MX2010009978A (ru) |
| MY (1) | MY169947A (ru) |
| PT (1) | PT2265135T (ru) |
| RU (1) | RU2495927C2 (ru) |
| SG (1) | SG188887A1 (ru) |
| UA (1) | UA100551C2 (ru) |
| WO (1) | WO2009112361A2 (ru) |
| ZA (1) | ZA201007327B (ru) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2008015950A (es) * | 2006-06-13 | 2009-01-09 | Nestec Sa | Prevencion y tratamiento de la otitis media. |
| CN101273738B (zh) * | 2007-03-28 | 2011-06-01 | 哈尔滨正方科技有限公司 | 在常温下保持高活菌数的调配型酸性乳饮料的制备方法 |
| US8498729B2 (en) * | 2008-08-29 | 2013-07-30 | Smp Logic Systems Llc | Manufacturing execution system for use in manufacturing baby formula |
| WO2011092261A1 (en) * | 2010-01-28 | 2011-08-04 | Ab-Biotics S.A. | Probiotic composition for use in the treatment of bowel inflammation |
| EP2658400A2 (en) | 2010-12-31 | 2013-11-06 | Abbott Laboratories | Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof |
| MX388089B (es) | 2010-12-31 | 2025-03-19 | Abbott Lab | Metodos para usar los oligosacaridos de leche humana para mejorar la salud respiratoria de las vias aereas. |
| EP3338784B1 (en) * | 2010-12-31 | 2020-07-22 | Abbott Laboratories | Human milk oligosaccharides for modulating inflammation |
| DK2658399T4 (da) | 2010-12-31 | 2024-03-25 | Abbott Lab | Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion |
| JP5331156B2 (ja) | 2011-04-28 | 2013-10-30 | シャープ株式会社 | 投光ユニットおよび投光装置 |
| PT2734049T (pt) | 2011-06-20 | 2018-07-24 | Heinz Co Brands H J Llc | Composições e métodos probióticos |
| PL2768313T3 (pl) * | 2011-10-18 | 2016-02-29 | Nestec Sa | Kompozycja do stosowania dla zwiększania absorpcji magnezu oraz/albo retencji magnezu w organizmie |
| KR101381794B1 (ko) * | 2012-04-10 | 2014-04-07 | 씨제이제일제당 (주) | 타가토스 및 프로바이오틱 유산균을 함유하는 신바이오틱 식품 조성물 |
| EP2928325A1 (en) * | 2012-12-10 | 2015-10-14 | N.V. Nutricia | Nutritional composition with non digestible oligosaccharides |
| ES2856013T3 (es) | 2013-11-15 | 2021-09-27 | Nestle Sa | Composiciones para su uso en la prevención o tratamiento de infecciones del TRS en bebés o niños jóvenes en riesgo |
| WO2015140299A1 (en) | 2014-03-20 | 2015-09-24 | Universiteit Antwerpen | Oronasopharyngeal probiotics |
| MX380540B (es) | 2015-03-05 | 2025-03-12 | Soc Des Produits Nestle S A Star | Composiciones para uso en la prevención o el tratamiento de otitis o bronquitis en infantes o niños pequeños. |
| MX378680B (es) | 2015-03-05 | 2025-03-11 | Soc Des Produits Nestle S A Star | Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños. |
| CA3030809A1 (en) | 2016-07-28 | 2018-02-01 | Fonterra Co-Operative Group Limited | Sialyloligosaccharide product and process |
| GB202415791D0 (en) * | 2024-10-25 | 2024-12-11 | Infant Bacterial Therapeutics Ab | Uses and methods |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839281A (en) | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
| WO1991016449A1 (en) * | 1990-04-16 | 1991-10-31 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
| ES2124060T5 (es) | 1992-07-06 | 2002-12-16 | Nestle Sa | Bacteria lactica. |
| ATE161181T1 (de) * | 1992-07-06 | 1998-01-15 | Nestle Sa | Lactobacillus acidophilus enthaltende antigastritis-mittel |
| FI104465B (fi) | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
| US6045854A (en) * | 1997-03-31 | 2000-04-04 | Abbott Laboraties | Nutritional formulations containing oligosaccharides |
| EP1034787A1 (en) | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactobacillus strains preventing diarrhea caused by pathogenic bacteria |
| AUPQ275799A0 (en) * | 1999-09-10 | 1999-10-07 | Luminis Pty Limited | Recombinant bacterium expressing an oligosaccharide receptor mimic |
| EP1411952B1 (en) * | 2001-06-29 | 2009-04-22 | Glykos Finland Oy | Use of at least one glycoinhibitor substance against infectious diseases |
| EP2272522B1 (en) * | 2002-06-28 | 2017-09-06 | Nestec S.A. | Therapeutic compositions for use in prophylaxis or treatment of diarrheas |
| GB0308104D0 (en) * | 2003-04-08 | 2003-05-14 | Novartis Nutrition Ag | Organic compounds |
| WO2005089564A1 (en) * | 2004-03-19 | 2005-09-29 | Danisco A/S | Emulsifier composition for shortening |
| DK1629850T4 (da) * | 2004-08-24 | 2013-07-01 | Nutricia Nv | Næringssammensætning indeholdende ufordøjelige oligosaccharider |
| EP1776877A1 (en) | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
| US9005682B2 (en) * | 2006-03-07 | 2015-04-14 | Nestec S.A. | Synbiotic mixture |
| BRPI0708701A2 (pt) * | 2006-03-10 | 2011-06-07 | Nutricia Nv | uso de um sacarìdeo não digerìvel solúvel em água |
| US7374924B2 (en) * | 2006-06-05 | 2008-05-20 | Biogaia Ab | Use of selected lactic acid bacteria for reducing infantile colic |
| EP2060257A1 (en) | 2007-11-08 | 2009-05-20 | Nestec S.A. | Prevention and treatment of secondary infections following viral infection |
| WO2009060257A2 (en) | 2007-11-09 | 2009-05-14 | Acco Uk Limited | Staple remover |
-
2009
- 2009-02-24 EP EP09719188.6A patent/EP2265135B1/en active Active
- 2009-02-24 RU RU2010142003/10A patent/RU2495927C2/ru active
- 2009-02-24 CN CN2009801129835A patent/CN102006788A/zh active Pending
- 2009-02-24 BR BRPI0909289-7A patent/BRPI0909289A2/pt active Search and Examination
- 2009-02-24 WO PCT/EP2009/052166 patent/WO2009112361A2/en not_active Ceased
- 2009-02-24 AU AU2009224814A patent/AU2009224814B2/en active Active
- 2009-02-24 UA UAA201012139A patent/UA100551C2/ru unknown
- 2009-02-24 CA CA2718222A patent/CA2718222A1/en not_active Abandoned
- 2009-02-24 ES ES09719188.6T patent/ES2658837T3/es active Active
- 2009-02-24 PT PT97191886T patent/PT2265135T/pt unknown
- 2009-02-24 SG SG2013018049A patent/SG188887A1/en unknown
- 2009-02-24 MY MYPI2010004274A patent/MY169947A/en unknown
- 2009-02-24 MX MX2010009978A patent/MX2010009978A/es active IP Right Grant
- 2009-02-24 US US12/922,377 patent/US8961953B2/en active Active
-
2010
- 2010-10-13 ZA ZA2010/07327A patent/ZA201007327B/en unknown
-
2013
- 2013-08-09 US US13/963,581 patent/US9254303B2/en active Active
-
2015
- 2015-12-22 US US14/978,064 patent/US9943556B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| UA100551C2 (en) | 2013-01-10 |
| CA2718222A1 (en) | 2009-09-17 |
| US8961953B2 (en) | 2015-02-24 |
| US20130323216A1 (en) | 2013-12-05 |
| BRPI0909289A2 (pt) | 2015-08-04 |
| WO2009112361A2 (en) | 2009-09-17 |
| US20160106788A1 (en) | 2016-04-21 |
| US9254303B2 (en) | 2016-02-09 |
| ES2658837T3 (es) | 2018-03-12 |
| WO2009112361A3 (en) | 2009-11-05 |
| PT2265135T (pt) | 2018-02-21 |
| MX2010009978A (es) | 2010-11-30 |
| MY169947A (en) | 2019-06-19 |
| US9943556B2 (en) | 2018-04-17 |
| ZA201007327B (en) | 2018-11-28 |
| RU2495927C2 (ru) | 2013-10-20 |
| AU2009224814A1 (en) | 2009-09-17 |
| EP2265135A2 (en) | 2010-12-29 |
| US20110020304A1 (en) | 2011-01-27 |
| SG188887A1 (en) | 2013-04-30 |
| AU2009224814B2 (en) | 2015-02-05 |
| CN102006788A (zh) | 2011-04-06 |
| EP2265135B1 (en) | 2017-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010129685A (ru) | Предупреждение оппортунистических инфекций у индивидуумов с нарушенным иммунитетом | |
| RU2008139598A (ru) | Синбиотическая смесь | |
| RU2011139211A (ru) | Бактериальные штаммы, обладающие высокой противовоспалительной активностью | |
| RU2009139657A (ru) | Снижение риска диареи | |
| RU2008136876A (ru) | Применение bifidobacterium longum для предупреждения и лечения воспаления | |
| RU2016129186A (ru) | Композиция, содержащая пробиотические бактерии, для применения в лечении иммунных расстройств | |
| MX337667B (es) | Combinacion simbiotica para mejorar la microbiota intestinal. | |
| RU2009100890A (ru) | Профилактика и лечение воспаления среднего уха с помощью непатогенных штаммов бактерий | |
| UA100551C2 (en) | Synbiotic mixture | |
| RU2011106319A (ru) | Пробиотики для увелечения секреции iga у младенцев, рожденных посредством кесарева сечения | |
| RU2010126327A (ru) | Композиция на основе пробиотических бактерий совместно с пребиотиком и ее применение в предупреждении и/или лечении респираторных патологий и/или инфекций и для улучшения функций кишечника | |
| RU2010153257A (ru) | Пробиотики для улудшения микробиоты пищеварительного тракта | |
| NZ593708A (en) | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin | |
| RU2008147883A (ru) | Применение молочнокислых бактерий для уменьшения детской колики | |
| CL2008000928A1 (es) | Uso de bacterias probioticas de las especies lactobacillus rhamnosus, cepas atcc 53103 ó cgmcc 13724 para la fabaricacion de un medicamento o formula infantil que permite reducir el riesgo de que el infante desarrolle obesidad a lo largo de su vida. | |
| EA201390305A1 (ru) | Композиции для влагалищного и перорального введения lactobacillus и их применение | |
| RU2013128570A (ru) | Олигосахаридная композиция для лечения острых инфекций дыхательных путей | |
| HRP20191096T1 (hr) | Sastavi koje sadrže bakterijske blautia sojeve za liječenje visceralne hipersenzitivnosti | |
| RU2010147343A (ru) | ИЗОЛИРОВАННЫЙ ШТАММ МИКРООРГАНИЗМА Lactobacillus plantarum Inducia DSM 21379 В КАЧЕСТВЕ ПРОБИОТИКА, УСИЛИВАЮЩЕГО ВРОЖДЕННЫЙ ИММУНИТЕТ ОРГАНИЗМА, ПРОДУКТ И КОМПОЗИЦИЯ, СОДЕРЖАЩИЕ УПОМОМЯНУТЫЙ МИКРООРГАНИЗМ, И ПРИМЕНЕНИЕ УПОМЯНУТОГО МИКРООРГАНИЗМА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА, КОТОРОЕ УСИЛИВАЕТ КЛЕТОЧНЫЙ ИММУНИТЕТ | |
| JP2016529309A5 (ru) | ||
| PH12013500931A1 (en) | Non-replicating probiotic micro-organisms protect against upper respiratory tract infections | |
| WO2007085970A3 (en) | Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders | |
| UA107711C2 (en) | Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic | |
| ATE534396T1 (de) | Probiotische mikroorganismen zur verbesserung der muskulären funktion | |
| RU2012117804A (ru) | Bifidobacterium longum atcc baa-999 (bl999) и контролирование веса |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC43 | Official registration of the transfer of the exclusive right without contract for inventions |
Effective date: 20190916 |